Clinical Utility of Pharmacogene Panel‐Based Testing in Patients Undergoing Percutaneous Coronary Intervention

• Main Authors: Nihal El Rouby (Author), Adel Alrwisan (Author), Taimour Langaee (Author), Gloria Lipori (Author), Dominick J Angiolillo (Author), Francesco Franchi (Author), Alberto Riva (Author), Amanda Elsey (Author), Julie A. Johnson (Author), Larisa H. Cavallari (Author), Almut G. Winterstein (Author)
• Format: Book
• Published: Wiley, 2020-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

We aimed to estimate the utility of panel‐based pharmacogenetic testing of patients undergoing percutaneous coronary intervention (PCI). Utilization of Clinical Pharmacogenetic Implementation Consortium (CPIC) level A/B drugs after PCI was estimated in a national sample of IBM MarketScan beneficiari...